ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest biopharma news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks biopharma across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
AusperBio secured $120 million in Series C funding to advance chronic hepatitis B therapies. The biopharma firm will use the capital to progress its clinical pipeline. The financing supports development of treatments targeting the chronic liver infection.
Summaries by ByteBrief